The American Journal of Managed Care: FDA Signals Potential Expansion of Testosterone Therapy to Treat Low Libido in Idiopathic Hypogonadism FDA is encouraging supplemental NDAs for TRT to treat low libido in idiopathic hypogonadism, reflecting preliminary conclusions from well-controlled trials and an expert panel review. Current approved ... FDA Signals Potential Expansion of Testosterone Therapy to Treat Low Libido in Idiopathic Hypogonadism Male hypogonadism is a condition in which the body doesn't make enough of the hormone testosterone or enough sperm or both.
Testosterone plays a key role in male growth and maturing during puberty. People can be born with male hypogonadism. Or it can start later in life, often from injury or infection. The cause of the condition and when it starts affect what can be done about it.
hypogonadism female, Testosterone ... Finding male hypogonadism in childhood can help prevent problems from delayed puberty. Early diagnosis and treatment in men helps protect against osteoporosis and other conditions. Testosterone therapy can help reverse the effects of hypogonadism, but it's unclear whether testosterone therapy would benefit older men who are otherwise healthy. Although some men believe they feel younger and more vigorous if they take testosterone medications, there's little evidence to support the use of testosterone in otherwise healthy men.
